• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 4. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes

Recent Advances in the Application of 2,3-Dichloro-6-nitrobenzyl Chloride (CAS: 192124-88-2) in Chemical Biology and Pharmaceutical Research

The chemical compound 2,3-Dichloro-6-nitrobenzyl Chloride (CAS: 192124-88-2) has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its reactive benzyl chloride group and nitro substitution, serves as a key intermediate in the synthesis of various biologically active molecules. Recent studies have explored its utility in drug discovery, particularly in the development of enzyme inhibitors and targeted therapeutics.

One of the most notable advancements involves the use of 2,3-Dichloro-6-nitrobenzyl Chloride as a building block for the synthesis of novel kinase inhibitors. Researchers have demonstrated its efficacy in forming covalent bonds with specific amino acid residues in the active sites of kinases, thereby enhancing inhibitor selectivity and potency. This approach has been particularly promising in the treatment of cancers driven by aberrant kinase activity, such as non-small cell lung cancer and chronic myeloid leukemia.

In addition to its role in kinase inhibition, recent publications highlight the compound's application in proteolysis-targeting chimeras (PROTACs). PROTACs are bifunctional molecules that recruit E3 ubiquitin ligases to target proteins for degradation. The reactive benzyl chloride moiety of 2,3-Dichloro-6-nitrobenzyl Chloride has been utilized to link E3 ligase ligands to target protein binders, enabling the development of highly specific degraders. This strategy has shown potential in addressing traditionally "undruggable" targets, such as transcription factors and scaffolding proteins.

Another emerging area of research involves the use of 2,3-Dichloro-6-nitrobenzyl Chloride in antibody-drug conjugates (ADCs). The compound's ability to form stable linkages with antibodies while maintaining payload activity has been leveraged to create next-generation ADCs with improved therapeutic indices. Recent preclinical studies have reported enhanced tumor targeting and reduced off-target effects when using this compound as a linker in ADC design.

From a synthetic chemistry perspective, novel methodologies have been developed to improve the efficiency of 2,3-Dichloro-6-nitrobenzyl Chloride production and derivatization. Green chemistry approaches, including catalytic processes and solvent optimization, have been implemented to reduce environmental impact while maintaining high yields. These advancements are critical for scaling up production to meet the growing demand in pharmaceutical applications.

Looking ahead, the unique chemical properties of 2,3-Dichloro-6-nitrobenzyl Chloride position it as a valuable tool in the continued evolution of targeted therapies. Ongoing research is exploring its potential in other therapeutic areas, including neurodegenerative diseases and infectious diseases. As our understanding of its reactivity and biological interactions deepens, this compound is likely to play an increasingly important role in drug discovery and development pipelines.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)